Michelle Petri, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Arthros-FocusMedEd
    Topic:
    SLE-Speaker
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Aurinia
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Axdev
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    03/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Boxer Capital
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Cabeletto Bio
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Caribou Biosciences
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    CTI Clinical Trial and Consulting Services
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    CVS Health
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Escient Pharmaceuticals
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024

Pages

Return to 2024 Inova Fairfax Medicine Grand Rounds 03/26/2024